Previous Article | Next Article ![]()
Applied and Environmental Microbiology, December 1999, p. 5222-5228, Vol. 65, No. 12
Lehrstuhl für Mikrobiologie,
Universität München, Munich,1 and
Institut für Mikrobiologie und Genetik, Technische
Universität Darmstadt, Darmstadt,2 Germany
Received 30 June 1999/Accepted 5 September 1999
To identify regulators of penicillin biosynthesis, a previously
isolated mutant of Aspergillus nidulans (Prg-1) which
carried the trans-acting prgA1 mutation was
used. This mutant also contained fusions of the penicillin biosynthesis
genes acvA and ipnA with reporter genes
(acvA-uidA and
ipnA-lacZ) integrated in a double-copy arrangement at the chromosomal argB gene. The
prgA1 mutant strain exhibited only 20 to 50% of the
ipnA-lacZ and acvA-uidA
expression exhibited by the wild-type strain and had only 20 to 30% of
the penicillin produced by the wild-type strain. Here, using
complementation with a genomic cosmid library, we isolated a gene
(suAprgA1) which complemented the prgA1
phenotype to the wild-type phenotype; i.e., the levels of expression of
both gene fusions and penicillin production were nearly wild-type
levels. Analysis of the suAprgA1 gene in the
prgA1 mutant did not reveal any mutation in the
suAprgA1 gene or unusual transcription of the gene. This
suggested that the suAprgA1 gene is a suppressor of the
prgA1 mutation. The suAprgA1 gene is 1,245 bp
long. Its five exons encode a deduced protein that is 303 amino acids
long. The putative SUAPRGA1 protein was similar to both the human p32
protein and Mam33p of Saccharomyces cerevisiae. Analysis of
the ordered gene library of A. nidulans indicated that
suAprgA1 is located on chromosome VI. Deletion of the
suAprgA1 gene resulted in an approximately 50% reduction in ipnA-lacZ expression and in a slight
reduction in acvA-uidA expression. The
Penicillin is a In A. nidulans, several regulators which are involved in the
regulation of penicillin biosynthesis have been identified. These regulators include the pH-dependent regulator PACC (8, 17, 29) and the CCAAT-binding complex PENR1 (AnCF), which resembles a
Hap-like complex (12, 18, 27). Both of these regulators have
the ability to bind to the DNAs of at least some of the penicillin biosynthesis gene promoters. To identify additional proteins involved in the regulation of penicillin biosynthesis, a mutant approach was
used (6). Briefly, we used strain AXTII9, an A. nidulans strain carrying acvA-uidA and
ipnA-lacZ gene fusions integrated in a
double-copy arrangement at the chromosomal argB gene locus. On Aspergillus minimal medium (AMM) agar plates supplemented
with 5-bromo-4-chloro-3-indolyl- Pérez-Esteban et al. (20) independently used a similar
approach which resulted in identification and characterization of a
recessive mutation designated npeE1 (impaired in penicillin biosynthesis). A genetic analysis showed that the mutation is located
on linkage group IV. To date, whether npeE1 differs from prgA1 and prgB1 has not been determined.
In this paper, we describe cloning and characterization of a gene which
complemented the prgA1 phenotype to the wild-type phenotype.
Strains and plasmids.
The bacterial and fungal strains used
in this study are listed in Table 1.
Vectors and plasmids were propagated in Escherichia coli
DH5
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Cloning and Characterization of an
Aspergillus nidulans Gene Involved in the Regulation of
Penicillin Biosynthesis
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
suAprgA1 strain produced about 60% of the amount of
penicillin produced by the wild-type strain.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactam
antibiotic that is produced only by filamentous fungi, most notably
Aspergillus nidulans and Penicillium chrysogenum
(4). Biosynthesis of penicillin starts from three amino acid
precursors, L-
-aminoadipic acid, L-cysteine,
and L-valine. This process is catalyzed by three enzymes,
which are encoded by the following three genes: acvA
(pcbAB), ipnA (pcbC), and
aatA (penDE), which encode
-(L-
-aminoadipyl)-L-cysteinyl-D-valine synthetase, isopenicillin N synthase, and acyl coenzyme A:isopenicillin N acyltransferase, respectively. The genes have been cloned and sequenced, and they are organized in a cluster (for reviews see references 4 and 19).
acvA and ipnA are divergently transcribed and in
A. nidulans and are separated by an 872-bp intergenic region (15).
-D-galactopyranoside
(X-Gal), colonies of this strain stained blue, which indicated that
ipnA-lacZ expression occurred. After mutagenesis
with UV light, colonies were isolated on agar plates containing lactose
as the carbon source, and these colonies produced only a faint blue
color or no color at all. The mutants (designated Prg mutants, for
penicillin regulation) most likely were defective in
trans-acting genes. It was not likely that mutants carrying
cis-acting mutations (i.e., mutations in the ipnA
promoter or the lacZ gene) would appear, because such mutations would probably not be detected due to the second gene fusion
located on the chromosome. This hypothesis was confirmed by a
complementation analysis which showed that the mutants carried trans-acting mutations. Two mutants (Prg-1 and Prg-6) with a
reproducible phenotype (white colonies on AMM agar plates containing
X-Gal and lactose as the carbon source) were characterized in detail. In a fermentation experiment, mutants Prg-1 and Prg-6 exhibited only 20 to 50% of the ipnA-lacZ expression exhibited by
the wild type and produced only 20 to 30% of the penicillin produced
by the wild type. A Western blot analysis showed that these mutants contained reduced amounts of the ipnA gene product (i.e.,
isopenicillin N synthase). Both mutant Prg-1 and mutant Prg-6 also
differed from the wild type in the level of
acvA-uidA expression. A segregation analysis
revealed that in both mutants the Prg phenotype resulted from mutation
of a single gene. Two different complementation groups were identified;
these groups were designated prgA1 and prgB1
(6).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
. Strain K103 was generated by crossing strain Prg-1 with G191
(Table 1). Ascospores were plated onto AMM agar plates containing X-Gal
(50 µg/ml) and glucose as the carbon source. Uracil-auxotrophic
colonies which stained the agar blue, which indicated that the
ipnA-lacZ gene fusion was present, were analyzed to determine whether the acvA-uidA and
ipnA-lacZ gene fusions were present in a
double-copy arrangement at the chromosomal argB gene locus,
as determined by Southern blotting as previously described (6). The presence of the prgA1 mutation was
checked by plating conidia onto AMM agar plates containing X-Gal (35 µg/ml) and lactose as the carbon source. In contrast to wild-type
strain AXTII9, the prgA1 mutants did not stain the
lactose-containing agar blue, which was due to the reduced
ipnA-lacZ expression under these conditions
(6). One of the resulting progeny with the desired genotype
was designated K103 (Table 1).
TABLE 1.
Bacteria, fungi, plasmids, and cosmids used in
this study
Gene libraries of A. nidulans. A genomic pCAP2 cosmid library (2), an ordered genomic gene library (7) (available from the Fungal Genetics Stock Center, Kansas City, Kans.), and a cDNA library (constructed by R. Aramayo; available from the Fungal Genetics Stock Center) of A. nidulans were used in this study.
Media and cultivation of strains. E. coli was grown in Luria-Bertani medium supplemented with ampicillin (50 µg/ml). AMM was prepared as previously described (6). A. nidulans fermentation was carried out in fermentation medium (FM) or AMM essentially as described previously (28). The seed cultures contained 4% (wt/vol) glucose and were cultivated for 24 h. Experimental cultures (20-ml portions of AMM or 20-ml portions of FM in 250-ml flasks) containing 4% (wt/vol) lactose as the carbon source were inoculated with 1 ml of a seed culture suspension, and the resulting preparations were incubated for various times, as indicated below. If required, biotin (0.3 µg/ml), p-aminobenzoic acid (15 µg/ml), L-arginine (0.5 mg/ml), uridine (1.2 mg/ml), or uracil (2.2 mg/ml) was added to the medium.
Penicillin bioassay and determination of dry weight. We performed penicillin bioassays in which Bacillus calidolactis C953 was the indicator organism and determined the dry weights of cultures as previously described (5).
Genetic techniques. Sexual crosses were performed and the resulting progeny were characterized as described by Pontecorvo et al. (21).
Standard DNA techniques. For small-scale preparation of A. nidulans chromosomal DNA, the technique of Raeder and Broda (23) was used. Standard techniques for manipulation of DNA were performed as described by Sambrook et al. (24). A Southern blot analysis and colony hybridization were performed essentially as described previously (24). DNA probes were labelled with fluorescein-11-dUTP and hybridized fragments were detected by Southern blot analysis by using an enhanced chemiluminescence (ECL) random prime kit (Amersham Pharmacia Biotech, Freiburg, Germany) and an ECL chemiluminescence kit (Amersham Pharmacia Biotech) respectively, according to the manufacturer's instructions. In vitro packaging in which chromosomal DNAs of the A. nidulans transformant strains were used was carried out by using a Gigapack III XL kit (Stratagene, La Jolla, Calif.).
Screening of the ordered gene library of A. nidulans.
To screen the ordered gene library, a
suAprgA1-specific probe was generated by PCR by using
chromosomal DNA of A. nidulans as the template and
oligonucleotides RevC and Tet4 as the primers (Table
2). The DNA fragment which was obtained
was 1.2 kbp long.
|
Generation of recombinant plasmids and probes for Southern blot analyses. The insert of the plasmid derived from transformant PrgA1CC was amplified by PCR by using oligonucleotides PC81 and PC82 (Table 2). In the case of the plasmid rescued from transformant PrgA1CB, a 1.3-kbp DNA fragment derived from the chromosomal insert was isolated by restriction digestion with HindIII and NcoI. The DNA fragments which were isolated were labelled, and the probes generated were used for Southern blot analysis.
To construct the suAprgA1 knock-out plasmid, we determined the DNA sequences flanking the suAprgA1 gene upstream and downstream (data not shown). Based on the information obtained, primers suAKOSal (encoding a SalI site) and suAKOKpn (encoding a KpnI site) (Table 2) were used to generate a 3.3-kbp DNA fragment by PCR; this fragment contained the suAprgA1 gene and about 1 kbp of the flanking region upstream and downstream. The PCR fragment was cut with SalI and KpnI and cloned into KpnI-SalI-digested vector pUC18. The resulting plasmid was designated pKO1. To delete the suAprgA1 gene from this plasmid, we used inverse PCR performed with oligonucleotides KOClaI (encoding a ClaI site) and KONotI (encoding a NotI site) (Table 2). A 4.6-kbp DNA fragment lacking the suAprgA1 gene from nucleotide
515
to nucleotide 793 was obtained. The DNA fragment was phosphorylated by
using polynucleotide kinase and ligated. E. coli cells were
transformed with the ligated DNA fragment, and the resulting plasmid
was designated pKO2. To introduce a selectable marker, plasmid pKO2 was
cut with ClaI and NotI, and a 2-kbp
ClaI-NotI DNA fragment obtained from plasmid
pKTB1 (Table 1) carrying the pyr-4 gene of Neurospora
crassa was ligated into the vector. The resulting plasmid was
designated pKO3 (see Fig. 5A).
PCR amplification, DNA sequence analysis, and computer programs. For PCR amplification, sequence-specific oligonucleotides were synthesized (MWG Biotech, Ebersberg, Germany). The DNA fragments produced were purified by using standard methods. The sequences of DNA fragments were determined on both strands by the dideoxy chain termination method (25) by using fluorescent dyes that were analysed with a model ABI PRISM 377 automatic sequencer (PE Biosystems, Weiterstadt, Germany). Sequence data were edited with the program Sequence Navigator (Applied Biosystems, Foster City, Calif.). Similarities between amino acid sequences were analyzed by using the program Gene Works (IntelliGenetics, Inc., Mountain View, Calif.).
Isolation of cDNAs.
To identify cDNA clones encoding
suAprgA1, DNAs from the A. nidulans
cDNA
library obtained by PCR were amplified by using internal primers
specific for the suAprgA1 gene derived from the genomic DNA
sequence and primer T3 (Stratagene) or T7 (Stratagene) essentially as
previously described (32).
Northern blot analysis. Mycelia of A. nidulans were harvested and broken by using liquid nitrogen as described previously (13). Total RNA was prepared by using an RNeasy total RNA purification kit (Qiagen, Hilden, Germany). The amount of RNA was determined both spectrophotometrically and by agarose gel electrophoresis. Northern blotting was performed as described by Sambrook et al. (24) by using the Gene Images system (Amersham Pharmacia Biotech).
Transformation of A. nidulans. A. nidulans K103 was transformed to uracil prototrophy by using a method described previously (1). For transformation, plasmid DNA was purified by chromatography performed with NUCLEOBOND columns as recommended by the manufacturer (Macherey and Nagel).
-GAL and
-GLU activity assays.
-Galactosidase
(
-GAL) and
-glucuronidase (
-GLU) activities were determined in
crude extracts by using mycelia grown in FM as previously described
(28). The
-GAL and
-GLU activities at each time point
were determined with cell extracts obtained from three cultures that
were incubated simultaneously. Protein concentrations were determined
as described by Bradford (3). Specific activities of
-GLU
and
-GAL were calculated as described previously (5).
Nucleotide sequence accession number. The nucleotide sequence of the A. nidulans suAprgA1 gene and the deduced amino acid sequence have been deposited in the EMBL database under accession no. Y17330.
| |
RESULTS |
|---|
|
|
|---|
Cloning of a gene that complements the PrgA1 phenotype. We attempted to clone a gene that complements the prgA1 phenotype by transformation by using an A. nidulans genomic library carrying the pyr-4 gene of N. crassa as the selectable marker. prgA1 mutant strain K103, which contained the pyrG89 mutation resulting in uracil auxotrophy, was used as the recipient. In addition, K103 carried the acvA-uidA and ipnA-lacZ gene fusions in a double-copy arrangement (see above). As previously shown, the growth of a strain carrying the prgA1 mutation in FM did not differ from the growth of a wild-type strain (6).
Strain K103 was transformed by using cosmid DNA from the genomic pCAP2 library. A total of 2,500 uracil-prototrophic transformants were isolated. Three of these (PrgA1CA, PrgA1CB, and PrgA1CC) complemented the prgA1 phenotype to the wild-type phenotype on agar plates containing X-Gal and lactose as the carbon source; i.e., the colonies stained the agar blue. In a penicillin fermentation analysis prgA1 mutant strain K103 exhibited reduced levels of acvA-uidA and ipnA-lacZ expression and produced less penicillin compared with wild-type strain AXTII9 (Wt) (Fig. 1A and B). The same results were obtained with a randomly chosen transformant, PrgA1T, which contained a noncomplementing cosmid. In contrast, in complemented transformants PrgA1CA, PrgA1CB, and PrgA1CC, the levels of acvA-uidA and ipnA-lacZ expression were greater than the levels observed in mutant strain K103 (Fig. 1A and B). In contrast to the prgA1 mutant, transformants PrgA1CA and PrgA1CB produced the same amount of penicillin as the wild-type strain produced (Fig. 1C). Transformant PrgA1CC even had a higher penicillin titer than the wild type (Fig. 1C).
|
was infected with DNA of transformant PrgA1CA, 11 ampicillin-resistant colonies were obtained. The cosmids of these colonies were isolated and analyzed by restriction analysis. Three different types of cosmids (cosCA.1, cosCA.2, and cosCA.3) were identified. With two of the cosmids (cosCA.1 and cosCA.3), 50% of the
transformants of prgA1 mutant strain K103 exhibited the wild-type phenotype on agar plates, indicating that the cosmids encoded
a gene which complemented the prgA1 phenotype (data not shown).
In order to reisolate the cosmid DNAs of transformants PrgA1CB and
PrgA1CC, total chromosomal DNAs of the transformants were digested by
HindIII and then ligated, which created circular
plasmids. These plasmids contained the ampicillin resistance gene, the
origin of replication in E. coli, and part of the A. nidulans chromosomal DNA derived from the cosmid up to the first
HindIII site in the genomic insert. In the case of
transformant PrgA1CB, an approximately 7-kbp plasmid was isolated, and
this plasmid corresponded to an estimated 3-kbp A. nidulans
chromosomal DNA insert. The border regions between the vector backbone
and the insert were sequenced. The plasmid derived from transformant
PrgA1CC in the same way contained a 220-bp insert (data not shown). A
comparison of the DNA sequences obtained with sequences from databases
did not reveal a major level of similarity to any previously described gene.
To analyze whether complementation of the different transformants was
due to the same DNA fragment, we used the sequence information for the
insert DNAs of both plasmids to design probes for Southern blot
analyses. Since these fragments were at the borders of the recombinant
parts of the cosmids, we expected that when the DNA fragments were used
as probes, the sizes of the hybridizing bands corresponding to the
chromosomal copy and additional bands would differ due to the
integration of cosmids.
BamHI-digested chromosomal DNAs of two wild-type strains,
DNAs of the three complemented transformants (PrgA1CA, PrgA1CB, and
PrgA1CC), and BamHI-digested DNAs of the three cosmids
rescued from transformant PrgA1CA were blotted onto a membrane and
hybridized with the probes derived from PrgA1CC (Fig.
2A) and PrgA1CB (Fig. 2B). As expected,
the PrgA1CC-derived probe (see above) hybridized with all of the
chromosomal DNAs (Fig. 2A). The additional signal at 6.2 kbp observed
with the chromosomal DNA of transformant PrgA1CC was due to integration
of the cosmid into the genome (Fig. 2A, lane 3). No additional band was
obtained with the chromosomal DNAs derived from transformants PrgA1CA
and PrgA1CB (Fig. 2A, lanes 4 and 5), and consequently, there was no
cross-reaction with the cosmid DNA isolated from transformant PrgA1CA
(Fig. 2A, lanes 6 through 8).
|
suAprgA1 gene.
To identify open reading frames
(ORFs) in the 3.7-kbp insert, Northern blotting (data not shown) and
computer analyses were performed. These analyses showed that only a
single ORF that resulted in a 1.2-kb mRNA transcript was fully encoded
by this DNA fragment. The corresponding cDNA of the gene that was
designated suAprgA1 (see below) was analyzed. The 5' end of
the suAprgA1 cDNA was located at position
35 with respect
to the putative translational initiation codon. The gene contained four
introns that were 159, 55, 79, and 49 bp long (EMBL accession no.
Y17330).
Comparison of the deduced SUAPRGA1 amino acid sequence with sequences in databases. A computer analysis in which the BLAST program was used revealed that the putative suAprgA1-encoded ORF was similar to a group of conserved proteins found in eukaryotes. This group includes the human p32 protein (11), Mam33p of Saccharomyces cerevisiae (16, 26), and a putative ORF of Schizosaccharomyces pombe (EMBL accession no. CAA22880). The overall levels of similarity at the amino acid level are 27% for SUAPRGA1 and Mam33p, 19% for SUAPRGA1 and p32, and 17% for Mam33p and p32. The region in these proteins that exhibited the highest level of similarity was the region at the C terminus (Fig. 3). The C-terminal parts of all of the proteins are rich in acidic and aliphatic amino acids (Fig. 3). All of the proteins have similar acidic isoelectric points. It is worth mentioning that a deletion of the S. cerevisiae Mam33 gene can be complemented by the human p32 protein gene (16). This suggests that despite the low overall level of similarity Mam33 and p32 are functional homologs.
|
suAprgA1 appears to be a suppressor of the prgA1 mutation. Our DNA sequence analysis of the suAprgA1 gene of Prg-1 (prgA1) and Prg-6 (prgB1) did not reveal any mutation in either the coding region or flanking regions. Also, the transcript of suAprgA1 was detected in the Prg-1 (prgA1) mutant strain (data not shown). Taken together, these findings suggested that the gene isolated is a suppressor of the prgA1 phenotype.
suAprgA1 is located on chromosome VI. To localize the suAprgA1 gene on one of the eight chromosomes of A. nidulans, the ordered A. nidulans gene library was screened by performing a Southern blot analysis (7, 22, 30). Using a suAprgA1-specific probe (see above), we obtained signals with cosmids L11A9, L11B9, L12B4, and W5E1 (data not shown) (9a). The cosmids were isolated, and PCR experiments confirmed that the suAprgA1 gene was present on these cosmids (data not shown). We found that all four of the cosmids carried chromosome VI DNA, indicating that the suAprgA1 gene is located on chromosome VI. In addition, cosmid L11A9 was fine mapped (9a). Interestingly, the penicillin biosynthesis gene cluster is located on the same chromosome (14) but in a different chromosomal region, suggesting that there is no physical linkage between suAprgA1 and the penicillin biosynthesis gene cluster.
Transcript of suAprgA1. To further analyze the suAprgA1 gene, the steady-state level of its mRNA was determined by Northern blot analysis (Fig. 4). The transcript was 1.2 kb long, which corresponds to the length of the cDNA sequence obtained. The gene was transcribed during growth in both FM and AMM. In FM, the relative abundance of mRNA decreased from 12 to 36 h, whereas considerable levels of mRNA were still detected in AMM after 48 h.
|
Deletion of suAprgA1. Since suAprgA1 appears to be a suppressor of the prgA1 phenotype, we decided to analyze the effect of a deletion of the suAprgA1 gene. Therefore, the knock-out plasmid pKO3 (see above) was cut with SphI and PvuII, which resulted in a linear fragment carrying the pyr-4 gene and on the two sides the 5' and 3' DNA sequences flanking the suAprgA1 gene (Fig. 5A). The linear fragment was used for transformation, which reduced the occurrence of transformants carrying ectopically integrated DNA.
|
suAprgA1 deletion strain DE58. The results are shown in
Fig. 6. After 24 h there was only a
slight difference between deletion mutant DE58 and wild-type strain
AXB4A with respect to expression of the ipnA-lacZ
fusion (Fig. 6B). However, in the later stages of fermentation
ipnA-lacZ expression did not increase any more in
the mutant strain, whereas it did increase in the wild-type strain
(Fig. 6B). Hence, after 48 h the level of expression of the
ipnA-lacZ gene fusion in the mutant was only
about 50% of the level of expression observed in the wild-type strain.
Deletion of the suAprgA1 gene resulted in only a slight
reduction in the level of acvA-uidA expression
(Fig. 6A). Determination of the penicillin titer revealed that
suAprgA1 strain DE58 produced about 60% of the amount of
penicillin produced by the wild-type strain (Fig. 6C). The reduction
was not due to production of a smaller amount of mycelium because in FM
the mutant strain grew as well as the wild-type strain and produced the
same mycelial mass (Fig. 6D). However, it is interesting that in
suAprgA1 deletion strain DE58 germination of conidia was
delayed (data not shown). Taken together, the data indicated that the
reduced levels of expression of both the acvA and
ipnA gene fusions were paralleled by a reduction in the
penicillin titer.
|
| |
DISCUSSION |
|---|
|
|
|---|
Previously, we described the isolation of two types of trans-acting mutations, designated prgA1 and prgB1, which affect penicillin biosynthesis in A. nidulans. The mutants exhibited reduced levels of expression of the penicillin biosynthesis genes acvA and ipnA and reduced penicillin titers (6). Here, we cloned and characterized a gene designated suAprgA1, which complemented the prgA1 phenotype nearly to the wild-type phenotype. This was accomplished by complementing the K103 (prgA1) mutant with a cosmid library. We isolated 3 complemented transformants from the 2,500 transformants examined. Two of these contained cosmids which carried the suAprgA1 gene. Isolation of the same gene from two independently isolated transformants confirmed the validity of this approach.
The isolated gene was designated a suppressor of the prgA1 mutation (suAprgA1). This conclusion was based on the results of an analysis of the DNA sequence of the chromosomal version of the suAprgA1 gene in the Prg-1 (prgA1) mutant. Furthermore, we detected no difference in the steady-state mRNA levels of suAprgA1 in the Prg-1 mutant and the wild type. However, mapping of the prgA1 mutation is required to prove that prgA1 and suAprgA1 are located at different genetic loci.
Complementation of the prgA1 phenotype was accomplished with a single copy of the cosmid present in the genome. This finding is unusual because in general, expression of suppressor genes from a high-copy-number plasmid is required for suppression of a mutant phenotype. At this time, we assume that a certain threshold concentration of a factor is required for full expression of the penicillin biosynthesis genes and thus full production of penicillin. In strains carrying the prgA1 mutation, the concentration of the factor falls short of the threshold concentration. The threshold concentration was already exceeded when an additional copy of the suAprgA1 gene was present in the cell.
Computer analysis revealed that the putative
suAprgA1-encoded protein was similar to a group of conserved
proteins found in eukaryotes. This group includes the human protein
designated p32 (11), Mam33p of S. cerevisiae
(16, 26), and a putative ORF of S. pombe (EMBL
accession no. CAA22880). The precise function of these proteins has not
been clarified yet. The crystal structure of the human p32 protein was
recently determined at 2.25 Å (10). Interestingly, the
secondary structure of SUAPRGA1 predicted by using the computer program
PredictProtein (EMBL database) suggested that this protein forms the
same C-terminal
-helices and most of the
-strands found in the
p32 protein (10). Thus, it is conceivable that SUAPRGA1
belongs to the p32 group of proteins. If this is true, it seems likely
that SUAPRGA1 represents a general factor which is not specific for
penicillin biosynthesis because it is also present in
non-penicillin-producing organisms. Rather, SUAPRGA1 appears to be
involved in generation of a physiological signal which is required for
full expression of the penicillin biosynthesis genes and thus
penicillin production. This hypothesis is supported by the observation
that overexpression of the suAprgA1 gene in A. nidulans when the alcA promoter of A. nidulans was used did not result in an increase in penicillin
production or expression of penicillin biosynthesis genes beyond the
levels observed in wild-type strains (unpublished data).
Further analysis of the function of the suAprgA1 gene in the aerobically growing fungus A. nidulans might also help clarify the function of the p32 protein homologs in various organisms.
| |
ACKNOWLEDGMENTS |
|---|
We thank Reinhard Fischer for providing the ordered A. nidulans gene library and Sybille Traupe for excellent help during some of the experiments.
This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 369).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institut für Mikrobiologie und Genetik, Technische Universität Darmstadt, Schnittspahnstr. 10, D-64287 Darmstadt, Germany. Phone: 49 6151 165566. Fax: 49 6151 162956. E-mail: brakhage{at}bio.tu-darmstadt.de.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ballance, D. J., and G. Turner. 1985. Development of a high-frequency transforming vector for Aspergillus nidulans. Gene 36:321-331[Medline]. |
| 2. | Borges-Walmsley, M. I., G. Turner, A. M. Bailey, J. Brown, J. Lehmbeck, and I. G. Clausen. 1995. Isolation and characterisation of genes for sulphate activation and reduction in Aspergillus nidulans: implications for evolution of an allosteric control region by gene duplication. Mol. Gen. Genet. 247:423-429[Medline]. |
| 3. | Bradford, M. M. 1976. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-252[Medline]. |
| 4. |
Brakhage, A. A.
1998.
Molecular regulation of beta-lactam biosynthesis in filamentous fungi.
Microbiol. Mol. Biol. Rev.
62:547-585 |
| 5. |
Brakhage, A. A.,
P. Browne, and G. Turner.
1992.
Regulation of Aspergillus nidulans penicillin biosynthesis and penicillin biosynthesis genes acvA and ipnA by glucose.
J. Bacteriol.
174:3789-3799 |
| 6. |
Brakhage, A. A., and J. Van den Brulle.
1995.
Use of reporter genes to identify recessive trans-acting mutations specifically involved in the regulation of Aspergillus nidulans penicillin biosynthesis genes.
J. Bacteriol.
177:2781-2788 |
| 7. |
Brody, H.,
J. Griffith,
A. J. Cuticchia,
J. Arnold, and W. E. Timberlake.
1991.
Chromosome-specific recombinant DNA libraries from the fungus Aspergillus nidulans.
Nucleic Acids Res.
19:3105-3109 |
| 8. | Espeso, E. A., J. Tilburn, L. Sánchez-Pulido, C. V. Brown, A. Valencia, H. N. Arst, Jr., and M. A. Peñalva. 1997. Specific DNA recognition by the Aspergillus nidulans three zinc finger transcription factor PacC. J. Mol. Biol. 274:466-480[Medline]. |
| 9. |
Fantes, P. A., and C. F. Roberts.
1973.
-Galactosidase activity and lactose utilization in Aspergillus nidulans.
J. Gen. Microbiol.
77:471-486.
|
| 9a. | Fungal Genome Resource Website. David Hall. [Online.] http://fungus.genetics.uga.edu:5080/CH6_MIN.txt. [12 October 1999, last date accessed.] |
| 10. |
Jiang, J.,
Y. Zhang,
A. R. Krainer, and R.-M. Xu.
1999.
Crystal structure of human p32, a doughnut-shaped acidic mitochondrial matrix protein.
Proc. Natl. Acad. Sci. USA
96:3572-3577 |
| 11. | Krainer, A. R., A. Mayeda, D. Kozak, and G. Binns. 1991. Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators. Cell 66:383-394[Medline]. |
| 12. | Litzka, O., P. Papagiannopoulos, M. A. Davis, M. J. Hynes, and A. A. Brakhage. 1998. The penicillin regulator PENR1 of Aspergillus nidulans is a HAP-like transcriptional complex. Eur. J. Biochem. 251:758-767[Medline]. |
| 13. | Litzka, O., K. Then Bergh, and A. A. Brakhage. 1995. Analysis of the regulation of Aspergillus nidulans penicillin biosynthesis gene aat (penDE) encoding acyl coenzyme A:6-aminopenicillanic acid acyltransferase. Mol. Gen. Genet. 249:557-569[Medline]. |
| 14. | MacCabe, A. P., M. B. R. Riach, S. E. Unkles, and J. R. Kinghorn. 1990. The Aspergillus nidulans npeA locus consists of three contiguous genes required for penicillin biosynthesis. EMBO J. 9:279-287[Medline]. |
| 15. |
MacCabe, A. P.,
H. van Liempt,
H. Palissa,
S. E. Unkles,
M. B. R. Riach,
E. Pfeifer,
H. von Döhren, and J. R. Kinghorn.
1991.
-(L- -Aminoadipyl)-L-cysteinyl-D-valine synthetase from Aspergillus nidulans molecular characterization of the acvA gene encoding the first enzyme of the penicillin biosynthetic pathway.
J. Biol. Chem.
266:12646-12654 |
| 16. |
Muta, T.,
D. Kang,
S. Kitajima,
T. Fujiwara, and N. Hamasaki.
1997.
p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation.
J. Biol. Chem.
272:24363-24370 |
| 17. |
Orejas, M.,
E. A. Espeso,
J. Tilburn,
S. Sarkar,
H. N. Arst, Jr., and M. A. Peñalva.
1995.
Activation of the Aspergillus PacC transcription factor in response to alkaline ambient pH requires proteolysis of the carboxy-terminal moiety.
Genes Dev.
9:1622-1632 |
| 18. | Papagiannopoulos, P., A. Andrianopoulos, J. A. Sharp, M. A. Davis, and M. J. Hynes. 1996. The hapC gene of Aspergillus nidulans is involved in the expression of CCAAT-containing promoters. Mol. Gen. Genet. 251:412-421[Medline]. |
| 19. | Peñalva, M. A., R. T. Rowlands, and G. Turner. 1998. The optimization of penicillin biosynthesis in fungi. Trends Biotechnol. 16:483-489[Medline]. |
| 20. |
Pérez-Esteban, B.,
E. Gómez-Pardo, and M. A. Peñalva.
1995.
A lacZ reporter fusion method for the genetic analysis of regulatory mutations in pathways of fungal secondary metabolism and its application to the Aspergillus nidulans penicillin pathway.
J. Bacteriol.
177:6069-6076 |
| 21. | Pontecorvo, G., J. A. Roper, L. M. Hemmons, K. D. MacDonald, and A. W. J. Bufton. 1953. The genetics of Aspergillus nidulans. Adv. Genet. 5:141-238[Medline]. |
| 22. |
Prade, R. A.,
J. Griffith,
K. Kochut,
J. Arnold, and W. E. Timberlake.
1997.
In vitro reconstruction of the Aspergillus (= Emericella) nidulans genome.
Proc. Natl. Acad. Sci. USA
94:14564-14569 |
| 23. | Raeder, U., and P. Broda. 1985. Rapid preparation of DNA from filamentous fungi. Lett. Appl. Microbiol. 1:17-20. |
| 24. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, N.Y |
| 25. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 26. | Seytter, T., F. Lottspeich, W. Neupert, and E. Schwarz. 1998. Mam33p, an oligomeric, acidic protein in the mitochondrial matrix of Saccharomyces cerevisiae, is related to the human complement receptor gC1q-R. Yeast 14:303-310[Medline]. |
| 27. |
Steidl, S.,
P. Papagiannopoulos,
O. Litzka,
A. Andrianopoulos,
M. A. Davis,
A. A. Brakhage, and M. J. Hynes.
1999.
AnCF, the CCAAT binding complex of Aspergillus nidulans, contains products of the hapB, hapC and hapE genes and is required for activation by the pathway-specific regulatory gene amdR.
Mol. Cell. Biol.
19:99-106 |
| 28. |
Then Bergh, K.,
O. Litzka, and A. A. Brakhage.
1996.
Identification of a major cis-acting DNA element controlling the bidirectionally transcribed penicillin biosynthesis genes acvA (pcbAB) and ipnA (pcbC) of Aspergillus nidulans.
J. Bacteriol.
178:3908-3916 |
| 29. | Tilburn, J., S. Sarkar, D. A. Widdick, E. A. Espeso, M. Orejas, J. Mungroo, M. A. Peñalva, and H. N. Arst, Jr. 1995. The Aspergillus PacC zinc finger transcription factor mediates regulation of both acidic- and alkaline-expressed genes by ambient pH. EMBO J. 14:779-790[Medline]. |
| 30. |
Wang, Y.,
R. A. Prade,
J. Griffith,
W. E. Timberlake, and J. Arnold.
1994.
A fast random cost algorithm for physical mapping.
Proc. Natl. Acad. Sci. USA
91:11094-11098 |
| 31. | Weidner, G., C. d'Enfert, A. Koch, P. Mol, and A. A. Brakhage. 1998. Development of a homologous transformation system for the human pathogenic fungus Aspergillus fumigatus based on the pyrG gene encoding orotidine monophosphate decarboxylase. Curr. Genet. 33:378-385[Medline]. |
| 32. | Weidner, G., B. Steffan, and A. A. Brakhage. 1997. The Aspergillus nidulans lysF gene encodes homoaconitase, an enzyme involved in the fungus-specific lysine biosynthesis pathway. Mol. Gen. Genet. 255:237-247[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|